×

BRIEF-Repros Therapeutics says FDA reclassifies Proellex clinical hold status

Oct 8 (Reuters) - Repros Therapeutics Inc :

* Says FDA agrees to reclassification of full clinical hold on further oral

Proellex studies to partial clinical hold

* Source text * Further company coverage

((Bangalore Newsroom; +1 646 223 8780))